Correlating the Tumoral Metabolic Progression Index to Patient's Outcome in Advanced Colorectal Cancer

Study ID
NCT01591590

Study type
Interventional

Study phase
Not Applicable

Study status
Completed

Trial Acronym

CORIOLAN

Trial Summary

The purpose of this study is to assess whether in a population of patients with advanced colorectal cancer for which no known effective therapy is available, measuring the spontaneous evolution of tumoral metabolic progression index by serial FGD PET-CT and Diffusion MRI can show that tumor growth rate is related to the patient's outcome, and that serial FDG PET-CT and Diffusion MRI are able to measure it.

More informations

Trial Starting Date

Jun 30,2012

Requirements

Gender All
Minimum age 18 Years
Maximum age N/A

Enrollement Limit